MRI Interventions to Present at Sidoti & Co. 2018 Fall Conference on Sept 27
LOS ANGELES, Sept. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC), announced today that Chief Executive Officer Joe Burnett will present at the Sidoti & Co. 2018 Fall Conference on Thursday, September 27, 2018, at 3:15 pm Eastern Time. The event will be held at the New York Grand Hyatt Hotel.
Management will be available to meet with investors throughout the day. Investors wishing to schedule a meeting should contact Sidoti & Co. at email@example.com or Matt Kreps, MRI Interventions Investor Relations at firstname.lastname@example.org.
About MRI Interventions, Inc.Building on the power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Forward-Looking StatementsStatements herein concerning MRI Interventions, Inc.’s plans, growth and strategies may include forward-looking statements within the context of the federal securities laws. Statements regarding the company’s future events, developments and future performance, as well as management’s expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. Uncertainties and risks may cause the company’s actual results to differ materially from those expressed in or implied by forward-looking statements. Particular uncertainties and risks include those relating to: the Company’s ability to obtain additional financing; estimates regarding the sufficiency of the Company’s cash resources; future revenues from sales of the company’s ClearPoint Neuro Navigation System products; and the company’s ability to market, commercialize and achieve broader market acceptance for the company’s ClearPoint Neuro Navigation System products. More detailed information on these and additional factors that could affect the company’s actual results are described in the “Risk Factors” section of the company’s Annual Report on Form 10-K for the year ended December 31, 2017, and its Quarterly Report on Form 10-Q for the three months ended June 30, 2018, both of which have been filed with the Securities and Exchange Commission.
Contact Information:Matt Kreps, Darrow Associates Investor Relations(214) 597-8200 email@example.com